Chinese Rheumatism Biobank(CRB)

Early prediction of major organ damage in SLE needs to dynamically track the evolution of SLE patients before and after the onset of major organ damage, and analyze the microscopic molecular evolution patterns synchronized with the macroscopic pathophysiological changes.

NCT Number	NCT06887517
Lead Sponsor	Chinese SLE Treatment And Research Group
Conditions	Lupus Erythematosus, Systemic
Enrollment	300 participants
Start Date	2025-02-10
Primary Completion	2028-04-01 (estimated)
Study Completion	2033-04-01 (estimated)
Updated on ClinicalTrials.gov	2025-04-09